Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. Nutalai R, Zhou D, Tuekprakhon A, Ginn HM, et al. Cell 2022;185:2116-2131.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nutalai R, Zhou D, Tuekprakhon A, Ginn HM, et al. Potent cross-reactive antibodies following Omicron breakthrough in vaccinees. Cell 2022;185:2116-2131.
PMID: 35662412